Chester County News and Community Website
WAYNE, PA — Cornelis Networks, a front-runner in the provision of intelligent, high-performance networking solutions, has unveiled the Cornelis™ CN5000 Omni-Path™. This high-performance interconnect product family is specifically designed to …
Cornelis Networks Introduces High-performance CN5000 Omni-Path Interconnect Family for AI and HPC environments Read More
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …
Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …
Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More
MALVERN, PA — Advanced Technology Services Group (ATS) has announced an expansion of its ATS Power Cloud, a top-tier cloud solution designed specifically for IBM Power Systems environments. This comes …
Advanced Technology Services Group Expands Power Cloud Solution for IBM Power Systems Environments Read More
EXTON, PA — Genzeon has recently announced the launch of HIP One – a secure intelligence platform expertly designed for the healthcare industry. HIP One is set to revolutionize the …
Genzeon Unveils HIP One – A Groundbreaking Healthcare Intelligence Platform Powered by GenAI Read More
MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced the commencement of its Phase 1/2 GARDian clinical trial for OCU410ST (AAV5-hRORA), a gene therapy candidate being developed to …
Ocugen Initiates Phase 1/2 GARDian Clinical Trial for Stargardt Disease Therapy Read More
BERWYN, PA — In a recent breakthrough, Annovis Bio (NYSE: ANVS), a biopharmaceutical company, has successfully performed measurements of critical biomarkers in the plasma of Parkinson’s disease patients. Utilizing buntanetap, …
Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease Read More
BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …
Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases, recently announced a significant milestone in its clinical trial journey. The …
Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward Read More
EXTON, PA — United Safety & Survivability Corporation, headquartered in Exton, Pennsylvania, has announced the launch of its groundbreaking innovation – a Lithium-Ion Battery Failure Detection Sensor. This product represents …
Exton-Based United Safety & Survivability Corporation Launches Lithium-Ion Battery Failure Detection Sensor Read More